Literature DB >> 30747735

Current opinion about antimicrobial therapy in palliative care: an update.

Filipa Macedo1, Nuno Bonito.   

Abstract

PURPOSE OF REVIEW: The review englobes the latest studies published regarding the problem of antimicrobial usage with palliative intent. RECENT
FINDINGS: In the advanced stages of illness like cancer, dementia, or neurodegenerative diseases, important decisions have to be made concerning the global treatment plan. Infections are very common among this kind of patients as they typically have multiple comorbidities and are incapacitated. These infections, in a majority of the cases, will be treated with antimicrobial therapy because this is a standard medical procedure. For a health professional, the decision of whether to treat, withhold, or withdraw a treatment can be difficult. In fact, in palliative care, the challenge is to balance compassionate care for people suffering from end-of-life diseases with the need for responsible antibiotic usage. Antimicrobial treatment could alleviate symptoms from an infection and make patients more comfortable, on the other hand, its overuse of it could bring a broader public health risk.
SUMMARY: On the contrary, in 18 months there are few studies about this problem, what reveals no concern about the use of antimicrobians in end-of-life patients.

Entities:  

Year:  2019        PMID: 30747735     DOI: 10.1097/CCO.0000000000000514

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  1 in total

1.  Characterization of Antibiotic Use, Documented Infection and Prevalence of Multidrug-Resistant Organisms in Palliative Care Patients Admitted to a Private Hospital in Brazil: A Retrospective, Cohort Study.

Authors:  Mara Graziele Maciel; Mayra Fruitg; Rebeca Pissolati Lawall; Alexandre Toledo Maciel
Journal:  Indian J Palliat Care       Date:  2021-11-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.